A Study to Examine the Safety, Tolerability and Effects on Abnormal Bone Formation of REGN2477 in Patients With Fibrodysplasia Ossificans Progressiva
Clinical trial NCT03188666 · COMPLETED
Trial details
- NCT number
- NCT03188666
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2019-09-16
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.